13:30-15:00

Registration

15:00-15:15

Welcome Address

Chair EDEG Steering Committee: Dorte Vistisen

Chair of the local organizing committee: Femke Rutters

15:15-16:00

Plenary Session 1

The National public health institute’s perspective on type 2 diabetes in the Netherlands: Burden of disease, determinants, prevention efforts, policy and politics

Hans Brug (director-general of the RIVM: Dutch National institute for Public Health and the Environment)

Chair: Joline Beulens, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

16:00-17:00

Oral Presentations, session 1: Diabetes prevention

Chairs:

Allison Shapiro, University of Colorado Anschutz Medical Campus, United States of America

Marinella Temprosa, George Washington university, United States of America

10 min.  presentations + 5 min. discussion

OP1

THE MOFIFYING ROLE OF ENVIRONMENTAL CHARACTERISTICS ON THE EFFECTIVENESS OF THE SLIMMER DIABETER PREVENTION LIFESTYLE INTERVENTION

Nicolette R den Braver, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

OP2

REAL-LIFE NUDGING, PRICING AND E-COACHING WAS NOT SUFFICIENT TO IMPROVE LIFESTYLE BEHAVIOURS AND CARDIOMETABOLIC HEALTH: THE SUPREME NUDGE PARALLEL CLUSTER-RANDOMISED CONTROLLED SUPERMARKET TRIAL

Joline W. J. Beulens, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

OP3

CUMULATIVE MEDIATING EFFECT OF DEXA-MEASURED TOTAL FAT MASS ON THE RELATIONSHIPS OF ACCELEROMETER-BASED MODERATE-TO-VIGOROUS PHYSICAL ACTIVITY WITH FASTING INSULIN AND INSULIN RESISTANCE FROM CHILDHOOD THROUGH YOUNG ADULTHOOD: A 13-YEAR LONGITUDINAL STUDY FROM ALSPAC BIRTH COHORT, UK

Andrew O. Agbaje, University of Eastern Finland, Institute of Public Health and Clinical Nutrition, School of Medicine, Finland

OP4

STRONG EDUCATIONAL AND INCOME DISPARITIES IN PREVALENCE OF T2 DIABETES BUT NOT T1 DIABETES IN DENMARK 2020

Bendix Carstensen, Steno Diabetes Center Copenhagen, Clinical Epidemiology, Denmark

17:00-17:30

Tea/coffee break

17:30-18:30

Oral Presentations, session 2: Mental health

Chairs:

Femke Rutters, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

Dino Gibertoni, University Hospital of Bologna, Research and Innovation Unit, Italy

10 min.  presentations + 5 min. discussion

OP5

ANTIDEPRESSANT PRESCRIBING AND CAUSE-SPECIFIC MORTALITY IN PEOPLE WITH COMORBID DEPRESSION AND TYPE 2 DIABETES: A UK PRIMARY CARE STUDY

Annie Jeffery, University College London, United Kingdom

OP6

SEVERE MENTAL ILLNESS AND CARDIOVASCULAR DISEASE AND MORTALITY IN PEOPLE TYPE 2 DIABETES: A NATIONWIDE COHORT STUDY

Sara Wild, University of Edinburgh, Usher Institute, United Kingdom

OP7

TRENDS IN THE ANNUAL PREVALENCE OF ANTIDEPRESSANT AND ANTIPSYCHOTIC DRUG PRESCRIBING IN PEOPLE WITH TYPE 2 DIABETES IN SCOTLAND FROM 2004 TO 2018

Charlotte Greene, University of Edinburgh, Usher Institute, United Kingdom

OP8

DIABETES DISTRESS AND DEPRESSION IN TYPE 2 DIABETES

Else-Marie Dalsgaard, Steno Diabetes Center Aarhus, Denmark

18:30-19:00

EDEG Business meeting – General Assembly

Welcome new board members

Thank leaving board members

19:00-20:00

Poster Pitches & Boards , session 1: Diversity

Chair: Peter Harms, Amsterdam UMC, General Practice, The Netherlands

Max. 2 min. poster pitches in the main hall, followed by ~40 minutes of questions/discussion next to poster boards in reception hall with drinks available

PP&B1

IMPACT OF MIGRATION ON DIABETES BURDEN: AUDIT IN THE METROPOLITAN AREA OF BOLOGNA

Dino Gibertoni University Hospital of Bologna, Research and Innovation Unit, Italy

PP&B2

DIABETES COMPLICATIONS RISK IN ETHNIC MINORITY POPULATIONS RESIDING IN EUROPE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Mirthe Muilwijk, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

PP&B3

TYPE 2 DIABETES RISK AFTER GESTATIONAL DIABETES ACCORDING TO COUNTRY/REGION OF ORIGIN. A DANISH NATIONWIDE REGISTER-BASED COHORT STUDY

Helene Nielsen, Steno Diabetes Center Copenhagen, Clinical Research, Denmark

PP&B4

DEMENTIA PATIENTS WITH A NON-WESTERN MIGRATION BACKGROUND AND THE USE OF HEALTH CARE: WHAT IS THE INFLUENCE OF A DIABETES DIAGNOSIS?

Bianca Strooij, Amsterdam UMC, General Practice, The Netherlands

PP&B5

EDUCATION LEVEL AND COUNTRY BACKGROUND IN YOUNG-ONSET TYPE 2 DIABETES

Katrina Tibballs, University of Oslo, Department of General Practice, Norway

PP&B6

SOCIOECONOMIC INEQUALITIES IN TYPE 2 DIABETES: THE ROLE OF HIGH DEMANDS, LOW CONTROL, AND LOW SUPPORT AT WORK IN THE MAASTRICHT STUDY

Bengisu Sezer, Maastricht University, Social Medicine, The Netherlands

PP&B7

ASSOCIATIONS BETWEEN DIMENSIONS OF THE SOCIAL ENVIRONMENT AND CARDIOMETABOLIC RISK FACTORS: SYSTEMATIC REVIEW AND META-ANALYSIS

Taymara C Abreu, Amsterdam UMC, Epidemiology and Data Science, The Netherlands

PP&B8

SOCIAL INEQUALITY IN USE OF DENTAL SERVICES AMONG PEOPLE WITH TYPE 2 DIABETES

Anette Andersen, Aarhus University Hospital, Steno Diabetes Center Aarhus, Denmark

PP&B9

REEVALUATING THE BURDEN OF FOOD INSECURITY IN YOUTH AND YOUNG ADULTS WITH DIABETES: THE IMPORTANCE OF MARGINAL FOOD SECURITY

Angela D Liese, University of South Carolina, Epidemiology and Biostatistics, United States of America

20:00

Welcome Dinner